Journal article
Peritoneal Dialysis Use and Practice Patterns: An International Survey Study.
- Cho Y Centre for Kidney Disease Research, University of Queensland, Brisbane, Australia; Translational Research Institute, Brisbane, Australia; Metro South and Ipswich Nephrology and Transplant Services (MINTS), Princess Alexandra Hospital, Brisbane, Australia. Electronic address: yeoungjee.cho@health.qld.gov.au.
- Bello AK Division of Nephrology and Immunology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.
- Levin A Division of Nephrology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
- Lunney M Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada.
- Osman MA Division of Nephrology and Immunology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.
- Ye F Division of Nephrology and Immunology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.
- Ashuntantang GE Faculty of Medicine and Biomedical Sciences, Yaounde General Hospital, University of Yaounde I, Yaounde, Cameroon.
- Bellorin-Font E Division of Nephology and Hypertension, Department of Medicine, Saint Louis University, Saint Louis, MO.
- Gharbi MB Urinary Tract Diseases Department, Faculty of Medicine and Pharmacy of Casablanca, University Hassan II of Casablanca, Casablanca, Morocco.
- Davison SN Division of Nephrology and Immunology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.
- Ghnaimat M Nephrology Division, Department of Internal Medicine, The Specialty Hospital, Amman, Jordan.
- Harden P Oxford Kidney Unit, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.
- Htay H Department of Renal Medicine, Singapore General Hospital, Singapore.
- Jha V George Institute for Global Health, UNSW, New Delhi, India; George Institute for Global Health, University of Oxford, Oxford, United Kingdom; Manipal Academy of Higher Education, Manipal, India.
- Kalantar-Zadeh K Division of Nephrology and Hypertension, University of California Irvine Medical Center, Orange, CA.
- Kerr PG Department of Nephrology, Monash Medical Centre, Monash Health, Clayton, Victoria, Australia; Department of Medicine, Monash University, Clayton, Victoria, Australia.
- Klarenbach S Division of Nephrology and Immunology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.
- Kovesdy CP University of Tennessee Health Science Center, Memphis, TN.
- Luyckx V Institute of Biomedical Ethics and the History of Medicine, University of Zurich, Zurich, Switzerland; Renal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
- Neuen B George Institute for Global Health, UNSW, New Delhi, India.
- O'Donoghue D Salford Royal NHS Foundation Trust, Salford, United Kingdom; University of Manchester, Manchester, United Kingdom.
- Ossareh S Division of Nephrology, Department of Medicine, Hasheminejad Kidney Center, Iran University of Medical Sciences, Tehran, Iran.
- Perl J Division of Nephrology, St. Michael's Hospital and the Keenan Research Centre in the Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada; Division of Nephrology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
- Rashid HU Department of Nephrology, Kidney Foundation Hospital and Research Institute, Dhaka, Bangladesh.
- Rondeau E Intensive Care Nephrology and Transplantation Department, Hopital Tenon, Assistance Publique-Hopitaux de Paris, Paris, France; Sorbonne Université, Paris, France.
- See EJ Department of Intensive Care, Austin Health, Melbourne, Australia; School of Medicine, University of Melbourne, Melbourne, Australia.
- Saad S Division of Nephrology and Immunology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.
- Sola L Dialysis Unit, CASMU-IAMPP, Montevideo, Uruguay.
- Tchokhonelidze I Nephrology Development Clinical Center, Tbilisi State Medical University, Tbilisi, Georgia.
- Tesar V Department of Nephrology, General University Hospital, Charles University, Prague, Czech Republic.
- Tungsanga K Department of Medicine, Faculty of Medicine, King Chulalong Memorial Hospital, Chulalongkorn University, Bangkok, Thailand; Bhumirajanagarindra Kidney Institute, Bangkok, Thailand.
- Kazancioglu RT Division of Nephrology, Bezmialem Vakif University, Istanbul, Turkey.
- Yee-Moon Wang A Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong.
- Yang CW Kidney Research Center, Department of Nephrology, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan.
- Zemchenkov A Department of Internal Disease and Nephrology, North-Western State Medical University named after I.I. Mechnikov, Saint Petersburg, Russia; Department of Nephrology and Dialysis, Pavlov First Saint Petersburg State Medical University, Saint Petersburg, Russia.
- Zhao MH Renal Division, Department of Medicine, Peking University First Hospital, Beijing, China; Key Lab of Renal Disease, Ministry of Health of China, Beijing, China; Key Lab of Chronic Kidney Disease Prevention and Treatment, Ministry of Education of China, Beijing, China; Peking-Tsinghua Center for Life Sciences (CLS), Beijing, China.
- Jager KJ ERA-EDTA Registry, Department of Medical Informatics, Academic Medical Center, Amsterdam Public Health Research Institute, University of Amsterdam, Amsterdam, the Netherlands.
- Caskey FJ Population Health Sciences, University of Bristol, Bristol, United Kingdom; Renal Unit, Southmead Hospital, North Bristol NHS Trust, Bristol, United Kingdom.
- Jindal KK Division of Nephrology and Hypertension, University of Cape Town, Cape Town, South Africa.
- Okpechi IG Kidney and Hypertension Research Unit, University of Cape Town, Cape Town, South Africa; Department of Medicine, University of Calgary, Calgary, Alberta, Canada.
- Tonelli M Pan-American Health Organization/World Health Organization's Collaborating Centre in Prevention and Control of Chronic Kidney Disease, University of Calgary, Calgary, Alberta, Canada; University of Leicester, Leicester, United Kingdom.
- Harris DC Centre for Transplantation and Renal Research, Westmead Institute for Medical Research, University of Sydney, Sydney, New South Wales, Australia.
- Johnson DW Centre for Kidney Disease Research, University of Queensland, Brisbane, Australia; Translational Research Institute, Brisbane, Australia; Metro South and Ipswich Nephrology and Transplant Services (MINTS), Princess Alexandra Hospital, Brisbane, Australia.
- 2020-08-18
Published in:
- American journal of kidney diseases : the official journal of the National Kidney Foundation. - 2020
Epidemiology
RRT modality
access to health care
affordability of health care
end-stage renal disease (ESRD)
global survey
health care delivery
health care disparities
health policy
home dialysis
international differences
kidney failure
peritoneal dialysis (PD)
renal replacement therapy (RRT)
English
RATIONALE & OBJECTIVE
Approximately 11% of people with kidney failure worldwide are treated with peritoneal dialysis (PD). This study examined PD use and practice patterns across the globe.
STUDY DESIGN
A cross-sectional survey.
SETTING & PARTICIPANTS
Stakeholders including clinicians, policy makers, and patient representatives in 182 countries convened by the International Society of Nephrology between July and September 2018.
OUTCOMES
PD use, availability, accessibility, affordability, delivery, and reporting of quality outcome measures.
ANALYTICAL APPROACH
Descriptive statistics.
RESULTS
Responses were received from 88% (n=160) of countries and there were 313 participants (257 nephrologists [82%], 22 non-nephrologist physicians [7%], 6 other health professionals [2%], 17 administrators/policy makers/civil servants [5%], and 11 others [4%]). 85% (n=156) of countries responded to questions about PD. Median PD use was 38.1 per million population. PD was not available in 30 of the 156 (19%) countries responding to PD-related questions, particularly in countries in Africa (20/41) and low-income countries (15/22). In 69% of countries, PD was the initial dialysis modality for≤10% of patients with newly diagnosed kidney failure. Patients receiving PD were expected to pay 1% to 25% of treatment costs, and higher (>75%) copayments (out-of-pocket expenses incurred by patients) were more common in South Asia and low-income countries. Average exchange volumes were adequate (defined as 3-4 exchanges per day or the equivalent for automated PD) in 72% of countries. PD quality outcome monitoring and reporting were variable. Most countries did not measure patient-reported PD outcomes.
LIMITATIONS
Low responses from policy makers; limited ability to provide more in-depth explanations underpinning outcomes from each country due to lack of granular data; lack of objective data.
CONCLUSIONS
Large inter- and intraregional disparities exist in PD availability, accessibility, affordability, delivery, and reporting of quality outcome measures around the world, with the greatest gaps observed in Africa and South Asia.
Approximately 11% of people with kidney failure worldwide are treated with peritoneal dialysis (PD). This study examined PD use and practice patterns across the globe.
STUDY DESIGN
A cross-sectional survey.
SETTING & PARTICIPANTS
Stakeholders including clinicians, policy makers, and patient representatives in 182 countries convened by the International Society of Nephrology between July and September 2018.
OUTCOMES
PD use, availability, accessibility, affordability, delivery, and reporting of quality outcome measures.
ANALYTICAL APPROACH
Descriptive statistics.
RESULTS
Responses were received from 88% (n=160) of countries and there were 313 participants (257 nephrologists [82%], 22 non-nephrologist physicians [7%], 6 other health professionals [2%], 17 administrators/policy makers/civil servants [5%], and 11 others [4%]). 85% (n=156) of countries responded to questions about PD. Median PD use was 38.1 per million population. PD was not available in 30 of the 156 (19%) countries responding to PD-related questions, particularly in countries in Africa (20/41) and low-income countries (15/22). In 69% of countries, PD was the initial dialysis modality for≤10% of patients with newly diagnosed kidney failure. Patients receiving PD were expected to pay 1% to 25% of treatment costs, and higher (>75%) copayments (out-of-pocket expenses incurred by patients) were more common in South Asia and low-income countries. Average exchange volumes were adequate (defined as 3-4 exchanges per day or the equivalent for automated PD) in 72% of countries. PD quality outcome monitoring and reporting were variable. Most countries did not measure patient-reported PD outcomes.
LIMITATIONS
Low responses from policy makers; limited ability to provide more in-depth explanations underpinning outcomes from each country due to lack of granular data; lack of objective data.
CONCLUSIONS
Large inter- and intraregional disparities exist in PD availability, accessibility, affordability, delivery, and reporting of quality outcome measures around the world, with the greatest gaps observed in Africa and South Asia.
- Language
-
- English
- Open access status
- closed
- Identifiers
-
- DOI 10.1053/j.ajkd.2020.05.032
- PMID 32800844
- Persistent URL
- https://sonar.ch/global/documents/64973
Statistics
Document views: 64
File downloads: